Naproxen Sodium

Product NDC: 50268-592
11-digit product format: 502680592
Labeler code: 50268
Product ID: 50268-592_b74afaaf-1442-41fe-8fab-f5dce214fff6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Naproxen Sodium
Dosage form: TABLET
Route: ORAL
Labeler: AvPAK
Application: ANDA078432
Marketing category: ANDA
Marketing start: 2007-04-26
Marketing end: 0000-00-00
Substance: NAPROXEN SODIUM
Active strength: 275 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50268-592		D	Discontinued by firm		2026-10-05
excluded package	package	50268-592	50268-592-15	D	Discontinued by firm		2026-10-05

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078432-001	NAPROXEN SODIUM	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL			2007-04-25
A078432-002	NAPROXEN SODIUM	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL			2007-04-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL		2007-04-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL		2007-04-25	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078432-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2007-04-25	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A078432-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2007-04-25	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 68 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078432-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078432-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078432-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078432-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078432-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078432-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078432-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078432-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078432-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078432-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078432-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078432-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078432-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078432-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078432-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A078432-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078432-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078432-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078432-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A078432-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078432-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A078432-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078432-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A078432-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078432-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A078432-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078432-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A078432-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078432-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078432-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078432-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A078432-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078432-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A078432-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078432-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A078432-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078432-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A078432-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078432-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A078432-002	AB	1	`b00525d2431f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50268-592-15	2022-02-03	C162847	48780-1	d6a99b39-d3ca-a426-e053-dadaa90af4c2	Naproxen Sodium Tablets, USP Rx Only These highlights do not include all the information needed to use NAPROXEN SODIUM TABLETS safely and effectively. See full prescribing information for NAPROXEN SODIUM TABLETS. N A P R O X E N SODIUM tablets, for oral use Initial U.S. Approval: 1976
50268-592-15	2022-01-28	C162847	48780-1	d6a99b39-d3ca-a426-e053-dadaa90af4c2	Naproxen Sodium Tablets, USP Rx Only These highlights do not include all the information needed to use NAPROXEN SODIUM TABLETS safely and effectively. See full prescribing information for NAPROXEN SODIUM TABLETS. N A P R O X E N SODIUM tablets, for oral use Initial U.S. Approval: 1976

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50268-592-11	EA - Each	50268-592	8f30aa62-0e57-4c4d-a484-9ea20324d4ad	1	2015-05-05
50268-592-15	EA - Each	50268-592	27557a3f-60bc-47bb-9cdf-b17da3e5ff49	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
NAPROXEN SODIUM	ACTIVE INGREDIENT	9TN87S3A3C	NAPROXEN SODIUM TABLET [AVPAK]	4
NAPROXEN	ACTIVE MOIETY	57Y76R9ATQ	NAPROXEN SODIUM TABLET [AVPAK]	4
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	NAPROXEN SODIUM TABLET [AVPAK]	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	NAPROXEN SODIUM TABLET [AVPAK]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NAPROXEN SODIUM TABLET [AVPAK]	4
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	NAPROXEN SODIUM TABLET [AVPAK]	4
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	NAPROXEN SODIUM TABLET [AVPAK]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	NAPROXEN SODIUM TABLET [AVPAK]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NAPROXEN SODIUM TABLET [AVPAK]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50268-592	NAPROXEN SODIUM TABLET [AVPAK]	8	Legacy NDC	20240105_9316bbe0-a194-d2a8-8f86-6d39e4d8f20e.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9TN87S3A3C	NAPROXEN SODIUM	26159-34-2	NAPROXEN SODIUM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50268-592-15	50268059215	50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-592-15) > 1 TABLET in 1 BLISTER PACK (50268-592-11)	50 blister pack	2012-10-16	0000-00-00	No	No	Current